Peter Ellmark
Alligator's cancer therapy platform granted patent in the US
Through its Neo-X-Prime platform, Alligator Bioscience has developed ATOR-4066 – a bispecific antibody that aims to strengthen immune cells in...
Intervju
Alligator Biosciences CSO presents CD40 portfolio at conference
Alligator Biosciences' CD40 agonist mitazalimab has recently shown promise...
Intervju
Neo-X-Prime – Alligator’s latest addition
Recently, Alligator Bioscience presented a new drug concept in...